Literature DB >> 2681117

Interactions in vitro between agents used to treat melioidosis.

D A Dance1, V Wuthiekanun, W Chaowagul, N J White.   

Abstract

Combinations of antimicrobial agents are usually recommended for the treatment of melioidosis. In Thailand, the conventional treatment regimen for Pseudomonas pseudomallei infections is a combination of chloramphenicol, doxycycline and cotrimoxazole. We have consistently observed antagonism between these agents during routine disc susceptibility testing. Interactions between these antimicrobials were studied further by a chequerboard microdilution method, using five clinical isolates of P. pseudomallei. Both trimethoprim and sulphamethoxazole antagonised the bacteriostatic activity of chloramphenicol and doxycycline. The combination of trimethoprim and sulphamethoxazole was synergistic, but not bactericidal. Bacteriostatic drugs antagonised the bactericidal activity of ceftazidime, which is undergoing clinical trials in severe melioidosis. These findings may be of therapeutic relevance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2681117     DOI: 10.1093/jac/24.3.311

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

1.  Pseudomonas pseudomallei, a common pathogen in Thailand that is resistant to the bactericidal effects of many antibiotics.

Authors:  T Sookpranee; M Sookpranee; M A Mellencamp; L C Preheim
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis.

Authors:  M Sookpranee; P Boonma; W Susaengrat; K Bhuripanyo; S Punyagupta
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

Review 3.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 4.  Suppressive drug combinations and their potential to combat antibiotic resistance.

Authors:  Nina Singh; Pamela J Yeh
Journal:  J Antibiot (Tokyo)       Date:  2017-09-06       Impact factor: 2.649

5.  Outcomes of patients with melioidosis treated with cotrimoxazole alone for eradication therapy.

Authors:  Sarunyou Chusri; Thanaporn Hortiwakul; Boonsri Charoenmak; Khachornsakdi Silpapojakul
Journal:  Am J Trop Med Hyg       Date:  2012-10-01       Impact factor: 2.345

6.  Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis.

Authors:  Allen C Cheng; Emma S McBryde; Vanaporn Wuthiekanun; Wirongrong Chierakul; Premjit Amornchai; Nicholas P J Day; Nicholas J White; Sharon J Peacock
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

7.  Melioidosis, phnom penh, Cambodia.

Authors:  Erika Vlieghe; Lim Kruy; Birgit De Smet; Chun Kham; Chhun Heng Veng; Thong Phe; Olivier Koole; Sopheak Thai; Lut Lynen; Jan Jacobs
Journal:  Emerg Infect Dis       Date:  2011-07       Impact factor: 6.883

Review 8.  Treatment and prophylaxis of melioidosis.

Authors:  David Dance
Journal:  Int J Antimicrob Agents       Date:  2014-02-03       Impact factor: 5.283

Review 9.  Melioidosis: Clinical impact and public health threat in the tropics.

Authors:  Ramar Perumal Samy; Bradley G Stiles; Gautam Sethi; Lina H K Lim
Journal:  PLoS Negl Trop Dis       Date:  2017-05-11

10.  Factors affecting clinical outcomes in the management of melioidosis in Singapore: a 16-year case series.

Authors:  Jaime Mei-Fong Chien; Seyed Ehsan Saffari; Ai-Ling Tan; Thuan-Tong Tan
Journal:  BMC Infect Dis       Date:  2018-09-26       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.